Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Board Changes

25 Aug 2016 07:00

RNS Number : 0802I
Phoenix Group Holdings
25 August 2016
 

 

Phoenix Group Holdings - Board Changes

 

The Board of Phoenix Group Holdings ("Phoenix") is pleased to announce the appointments of three new non-executive directors, Wendy Mayall, John Pollock and Nicholas Shott, all with effect from 1 September 2016.

 

Wendy Mayall has over thirty years' asset management experience, including as Group Chief Investment Officer and latterly consultant at Liverpool Victoria from 2012 to 2015, having previously been Chief Investment Officer for Unilever's UK pension fund from 1996 to 2011 and holding management responsibility for Unilever's pension funds globally. From 2006 to 2009, she was the Chair of the Investment Committee of the Mineworkers Pension Scheme, a British government appointment to one of the largest government backed pension schemes in the UK. Mrs Mayall is the non-executive Senior Independent Director of the Aberdeen UK Tracker Trust plc.

 

John Pollock had a highly successful career in life assurance at the Legal & General Group from 1980 to 2015, including as an executive director of Legal & General Group plc from 2003 to 2015. He held numerous senior roles, gaining wide strategic and technical experience, finally as Chief Executive Officer of LGAS (L&G Assurance Society), one of Legal and Generals' three primary business units, employing 6,000 staff. His previous roles included Chief Executive Officer (Protection and Annuities). Prior to his retirement from Legal and General in 2015, Mr Pollock held positions as Deputy Chair of the FCA Practitioner Panel, Chairman of investment platform Cofunds, and as a non-executive director of the Cala Homes Group.

 

Nicholas Shott is a highly experienced investment banker, who is European Vice Chairman of Lazard, a role he has held since 2007, and Head of UK Investment Banking at Lazard, which he has been since 2009. He joined Lazard in 1991 and became a partner in 1997. His wide experience of successfully advising clients on M&A deals in various sectors over many years is expected to be of significant benefit to Phoenix in pursuing its acquisition strategy.

 

The Phoenix Board also announces that Rene-Pierre Azria will be leaving the Board on 30 November 2016 after seven years as a non-executive director.

 

Commenting on the Board changes, Henry Staunton, Phoenix Chairman said: "I am delighted that we have secured the appointments to the Phoenix Board of three such experienced and successful individuals who will enhance the Board skillset in both quality and diversity. I would like to thank Rene-Pierre Azria for his valuable contribution to Phoenix since his appointment to the Board in September 2009 and through its progress as a premium listed company from July 2010. On behalf of all the Board, I wish him well."

 

No other information is required to be notified under Listing Rule 9.6.13 R.

 

Enquiries:

MediaNeil Bennett, MaitlandPeter Ogden, Maitland+ 44 (0) 20 7379 5151

InvestorsSam Perowne, Head of Investor Relations, Phoenix Group+44 (0) 203 735 0021

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPIMLTMBITBBF
Date   Source Headline
3rd Sep 20188:00 amRNSRe-admission of Phoenix Group Holdings
31st Aug 20185:45 pmRNSCompletion of Sale
31st Aug 20185:45 pmRNSCompletion of Standard Life Assurance Acquisition
31st Aug 20189:30 amRNSTotal Voting Rights
24th Aug 20184:15 pmRNSPublication of Suppl.Prospcts
23rd Aug 20184:46 pmRNSPublication of Suppl.Prospcts
23rd Aug 20187:00 amRNSHalf-year Report
10th Aug 20184:15 pmRNSHolding(s) in Company
10th Aug 20183:00 pmRNSDirector/PDMR Shareholding
3rd Aug 20187:00 amRNSChairman Appointment
31st Jul 20184:45 pmRNSTotal Voting Rights
27th Jul 20183:30 pmRNSDirector/PDMR Shareholding
27th Jul 20183:30 pmRNSDirector/PDMR Shareholding
23rd Jul 20187:00 amRNSWarrant Redemption Notice
13th Jul 20183:40 pmRNSDirector/PDMR Shareholding
13th Jul 201811:00 amRNSHolding(s) in Company
12th Jul 201812:30 pmRNSTotal Voting Rights
11th Jul 20184:45 pmRNSTotal Voting Rights
10th Jul 201812:40 pmRNSResults of Rump Placing
10th Jul 20189:15 amRNSHolding(s) in Company
10th Jul 20187:00 amRNSResults of Rights Issue
9th Jul 20182:45 pmRNSDirector/PDMR Shareholding
6th Jul 201810:45 amRNSDirector/PDMR Shareholding
6th Jul 201810:45 amRNSDirector/PDMR Shareholding
4th Jul 201812:30 pmRNSDirector/PDMR Shareholding
3rd Jul 20182:00 pmRNSHolding(s) in Company
2nd Jul 201812:45 pmRNSDirector/PDMR Shareholding
29th Jun 201811:45 amRNSTotal Voting Rights
28th Jun 20183:00 pmRNSHolding(s) in Company
28th Jun 20183:00 pmRNSDirector/PDMR Shareholding
26th Jun 20188:06 amRNSAdmission of Nil Paid Rights
25th Jun 20181:45 pmRNSResults of General Meeting
25th Jun 20187:03 amRNSDirectorate Change
25th Jun 20187:00 amRNSBoard Changes
8th Jun 201810:15 amRNSDirector Declaration
7th Jun 201810:00 amRNSDirector/PDMR Shareholding
6th Jun 20182:45 pmRNSHolding(s) in Company
31st May 20183:00 pmRNSTotal Voting Rights
30th May 201812:00 pmRNSPublication of Prospectus Circular & Notice of EGM
30th May 20187:00 amRNSLaunch of £950 million rights issue
22nd May 20189:59 amRNSPost Stabilisation Notice
21st May 201811:00 amRNSBlock Listing Application
11th May 20184:00 pmRNSDirector/PDMR Shareholding
10th May 20189:30 amRNSDirector Declaration
9th May 20182:46 pmRNSDirector/PDMR Shareholding
9th May 20182:45 pmRNSDirector/PDMR Shareholding
3rd May 201812:30 pmRNSUpdate on Standard Life Assurance Transaction
3rd May 201812:30 pmRNSUpdate on proposed transaction
2nd May 20183:30 pmRNSResult of AGM
2nd May 201810:19 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.